A detailed history of New York State Common Retirement Fund transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 5,200 shares of ELEV stock, worth $2,963. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,200
Previous 39,900 86.97%
Holding current value
$2,963
Previous $108,000 97.22%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$0.56 - $3.02 $19,432 - $104,794
-34,700 Reduced 86.97%
5,200 $3,000
Q2 2024

Jul 31, 2024

BUY
$2.35 - $5.17 $93,765 - $206,283
39,900 New
39,900 $108,000

Others Institutions Holding ELEV

About Elevation Oncology, Inc.


  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $13.3M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.